Private-Equity Firm Takes Profits on Aveanna’s 101% Stock Rally

As part of a trading plan, Paul R. Vigano, a 10% owner of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), sold 1,500,000 indirectly owned shares of the home healthcare services company for approximately $13.5 million on October 24, as disclosed in a recent SEC Form 4 filing.

Transaction Summary

The transaction value is based on the SEC Form 4 weighted average purchase price of $9.00 on October 24.

Key Questions

How does this transaction compare in scale to past insider sales?
The sale isn't abnormal for Vigano, who has executed several sales since March, when he held over 50 million shares indirectly.

What was the market context at the time of the sale?
Shares were priced at $9.00 each for this transaction on October 24. The stock had surged nearly 101% over the past 12 months.

What is the structure of indirect ownership following this transaction?
Following the sales, Vigano still owns about 40.1 million shares indirectly. He reported holding no shares directly.

Company Overview

Company Snapshot

Aveanna Healthcare Holdings Inc. is a leading provider of diversified home care services, operating at scale with over 33,000 employees nationwide. The company’s integrated care model emphasizes patient-centered delivery, enabling cost-effective treatment in the home and reducing hospital utilization. It generates revenue through in-home skilled nursing, therapy services, and delivery of medical nutrition products, leveraging a patient-centered care platform to reduce reliance on high-cost hospital settings. The company serves medically fragile children, adults requiring home health or hospice care, and individuals needing medical nutrition.

Foolish Take

Paul R. Vigano, a managing member at J.H. Whitney Capital Partners, sold 1.5 million indirectly owned shares of Aveanna Healthcare Holdings for about $13.5 million on October 24, according to an SEC Form 4 filing. The sale was conducted under a Rule 10b5-1 trading plan adopted in December through several J.H. Whitney–affiliated entities.

While large, the sale isn’t unusual—J.H. Whitney, a private-equity firm focused on small- and mid-market growth companies, has gradually trimmed its stake since spring, when it held over 50 million shares indirectly. Following the sale, Vigano and the affiliated investment vehicles still collectively control around 40 million shares, underscoring that the firm remains a major holder.

Aveanna shares, which have doubled over the past year but remain roughly 28% below their 2021 highs, reflect improving sentiment around home-care and pediatric health services. For long-term investors, this trade highlights a typical liquidity move by a private-equity backer after a prolonged holding period rather than a fundamental shift in confidence. With Aveanna’s integrated model across skilled nursing, therapy, and medical nutrition, the company remains positioned to benefit from the ongoing shift toward lower-cost, home-based care.

Glossary

Insider: An individual with access to non-public company information, often a major shareholder, executive, or director.
Form 4: A required SEC filing disclosing insider trades of a company's securities.
Direct ownership: Shares held personally by an individual, not through intermediaries or entities.
Indirect ownership: Shares owned through trusts, partnerships, or other entities rather than held personally.
Block sale: A large transaction involving a significant number of shares, typically executed outside open markets.
Disposition: The act of selling or otherwise transferring ownership of an asset or security.
Weighted average purchase price: The average price paid per share, weighted by the number of shares in each transaction.
Patient-centered care: A healthcare approach focusing on individual patient needs, preferences, and values.
Home health: Medical and support services delivered to patients in their own homes.
Hospice: Specialized care for terminally ill patients, focusing on comfort and quality of life.
Enteral nutrition: Delivery of nutrients directly into the digestive system, often via a feeding tube.
TTM: The 12-month period ending with the most recent quarterly report.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.